2C-P: Difference between revisions

>David Hedlund
Removed {{toxicity}} -- not a stub any more
>David Hedlund
{{GenericPanel/warning
Line 121: Line 121:


===Overdose===
===Overdose===
Pharmacokinetic factors that make 2C-P pretty unique and require notably caution:
{{GenericPanel/warning
* Steep dose-response curve: As little as a few extra milligrams separating a manageable dose and an overdose.<ref name="Erowid" /> Users who wish to take high doses of this compound are advised to titrate upward slowly, use reliable milligram scales to measure doses, and avoid non-oral routes of administration such as insufflation or injection.
| title=Pharmacokinetic factors that make 2C-P pretty unique and require notably caution
| content=* Steep dose-response curve: As little as a few extra milligrams separating a manageable dose and an overdose.<ref name="Erowid" /> Users who wish to take high doses of this compound are advised to titrate upward slowly, use reliable milligram scales to measure doses, and avoid non-oral routes of administration such as insufflation or injection.
* Very slow onset: The peak effects reportedly do not occur for 1 to 3 hours.<ref name="Erowid">{{Citation | title=Erowid Online Books : “PIHKAL” - #36 2C-P | url=https://www.erowid.org/library/books_online/pihkal/pihkal036.shtml}}</ref> Thus it's advised to wait for at least 3 hours before re-dosing is considered.
* Very slow onset: The peak effects reportedly do not occur for 1 to 3 hours.<ref name="Erowid">{{Citation | title=Erowid Online Books : “PIHKAL” - #36 2C-P | url=https://www.erowid.org/library/books_online/pihkal/pihkal036.shtml}}</ref> Thus it's advised to wait for at least 3 hours before re-dosing is considered.
* Long half-life: The anecdotal estimated elimination half-life is 19 hours.<ref>https://pubmed.ncbi.nlm.nih.gov/28130544/</ref>
* Long half-life: The anecdotal estimated elimination half-life is 19 hours.<ref>https://pubmed.ncbi.nlm.nih.gov/28130544/</ref>
}}<noinclude>[[Category:Panels]]</noinclude>


The LD<sub>50</sub> of 2C-P has not been established. However, it is believed that 2C-P is likely to have a smaller therapeutic window compared to other 2C's, meaning a lethal dose may be achieved more easily.
The LD<sub>50</sub> of 2C-P has not been established. However, it is believed that 2C-P is likely to have a smaller therapeutic window compared to other 2C's, meaning a lethal dose may be achieved more easily.
Retrieved from "http://psy.st/wiki/2C-P"